MARKET

IMCR

IMCR

Immunocore Holdings Plc
NASDAQ
32.82
+1.03
+3.22%
Opening 14:05 02/13 EST
OPEN
32.10
PREV CLOSE
31.79
HIGH
33.77
LOW
31.81
VOLUME
182.05K
TURNOVER
--
52 WEEK HIGH
40.71
52 WEEK LOW
23.15
MARKET CAP
1.66B
P/E (TTM)
-55.9506
1D
5D
1M
3M
1Y
5Y
1D
Assessing Immunocore Holdings (IMCR) Valuation After R&D Leadership Restructure
Simply Wall St · 1d ago
Leadership Shuffle in Immunocore’s R&D Suite Might Change The Case For Investing In IMCR
Simply Wall St · 4d ago
Weekly Report: what happened at IMCR last week (0202-0206)?
Weekly Report · 4d ago
Goldman Sachs Sticks to Its Buy Rating for Immunocore Holdings (IMCR)
TipRanks · 02/05 07:55
Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co.
Dow Jones · 02/04 13:47
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target
Benzinga · 02/04 13:40
Analysts Offer Insights on Healthcare Companies: DaVita (DVA) and Immunocore Holdings (IMCR)
TipRanks · 02/04 11:40
A Look At Immunocore Holdings (IMCR) Valuation As Analysts Reassess Pipeline And Leadership Changes
Simply Wall St · 02/04 07:33
More
About IMCR
Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a pipeline of clinical-stage programs in oncology and infectious diseases, as well as numerous pre-clinical projects. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-M113V, IMC-I109V, IMC-S118AI, and IMC-U120AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, ovarian, lung, colorectal and others.

Webull offers Immunocore Holdings PLC - ADR stock information, including NASDAQ: IMCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMCR stock methods without spending real money on the virtual paper trading platform.